These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1475774)

  • 21. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
    Gisbert JP; Pajares JM; Losa C
    Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitors and acid-related diseases.
    Sachs G
    Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Helicobacter pylori eradication: modified triple therapy with lansoprazole].
    Müller P; Simon B
    Fortschr Med; 1996 Dec; 114(35-36):497-9. PubMed ID: 9119351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Peptic ulcer disease etiology, diagnosis and treatment].
    Bak-Romaniszyn L; Wojtuń S; Gil J; Płaneta-Małecka I
    Pol Merkur Lekarski; 2004; 17 Suppl 1():128-32. PubMed ID: 15603370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-ulcer drug consumption in Spain].
    Carvajal A; García del Pozo J; del Olmo L; Rueda AM; Alvarez Requejo A
    Aten Primaria; 1999 Mar; 23(4):218-21. PubMed ID: 10333606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Guidelines of treatment for non-bleeding peptic ulcer disease].
    Cheung DY; Jung HY; Song HJ; Jung SW; Jung HC; ;
    Korean J Gastroenterol; 2009 Nov; 54(5):285-97. PubMed ID: 19934610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of peptic ulcers from now to the millennium.
    Pounder RE
    Baillieres Clin Gastroenterol; 1994 Jun; 8(2):339-50. PubMed ID: 7949462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The end of the era of maintenance therapy for peptic ulcer disease?
    Chiba T
    J Gastroenterol; 2000; 35(11):873. PubMed ID: 11085499
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adverse effects of drugs for peptic ulcer diseases].
    Haruma K; Kamada T; Shiotani A
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():266-71. PubMed ID: 23156519
    [No Abstract]   [Full Text] [Related]  

  • 40. The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932-2015).
    Buzás GM; Supuran CT
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):527-33. PubMed ID: 26108882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.